Skip to content
OpenCapital
Get started

CBIZ CBZ Performance share units (in shares)

Performance share units (in shares) at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
724.8K—
KEE
Keel Infrastructure Corp. Common StockKEEL
841.7K—
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
0-100%
Q2 Holdings logo
Q2 HoldingsQTWO
15K+200%
BGC Group, Inc. logo
BGC Group, Inc.BGC
0—
First BanCorp logo
First BanCorpFBP
839K+2.9%

Other financials

Income statement

See full
Revenue$848.6M+1.3%
Gross profit$226.0M-0.9%
Operating income$196.4M-1.8%
Net income$161.6M+31.6%
EPS (diluted)$2.63+37.7%

Balance sheet

See full
Cash & equivalents$177.1M+18.6%
Total debt$2.0B+2.0%
Total equity$1.9B-1.1%
Total assets$4.6B+1.0%

Cash flow

See full
Operating cash flow-$25.5M+71.1%
CapEx$3.0M-42.1%
Free cash flow-$28.5M+69.5%

Valuation

See full
Market cap$1.63B-63.7%
Enterprise value$3.44B-44.0%
P/E4.6×—
P/S0.6×-1.5×

Profitability

See full
Gross margin14.5%-0.6pp
Operating margin7.2%—
Net margin7.5%—
FCF margin8.7%+4.7pp

Returns & leverage

See full
Return on equity11.2%—
Debt / equity1.1×0.0×
Current ratio1.6×+0.1×

Where this comes from

Reported directly by CBIZ in its filing.

Tagged under the XBRL concept cbz:IncrementalCommonSharesAttributableToPerformanceShareUnits.

The official record: CBIZ’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about CBIZ's performance share units (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CBIZ's performance share units (in shares)?
CBIZ (CBZ) reported performance share units (in shares) of 110K in Q4 2025.
How has CBIZ's performance share units (in shares) changed year-over-year?
CBIZ's performance share units (in shares) decreased by 13.4% year-over-year, from 127K to 110K.
What does performance share units (in shares) mean?
Represents the number of common shares potentially issuable under performance-based equity compensation plans. This metric reflects the dilutive impact of equity awards that vest contingent upon the achievement of specific corporate performance goals. It is a key indicator of future share dilution and management's alignment with long-term performance targets.